β‑blockers inhibit the viability of breast cancer cells by regulating the ERK/COX‑2 signaling pathway and the drug response is affected by ADRB2 single‑nucleotide polymorphisms
Wan‐Ying Xie(Central South University), Jie Liu(Central South University), Yongjun Tang(Xiangya Hospital Central South University), Ruohui He(Central South University), Yijing He(Central South University), Chengfang Zhou(Army Medical University), Zhi Li(Central South University), Zan Wan(Central South University), Jun Zhang(Central South University), Howard L. McLeod(Central South University)
Cited by 28
Related Papers
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism
|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|2002|430
The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug Response
|Clinical Pharmacology & Therapeutics|2007|243
Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukaemia
|British Journal of Haematology|1999|128